RxNorm Semantic Concepts Index - 162
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "162".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 162 | Acetanilid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 162 | Acetanilid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 162 | Acetanilid | Designated preferred name (PT) | YES | |
| RxCUI: 162 | Acetanilid | Full form of descriptor (FN) | YES | |
| RxCUI: 1620479 | Free thiamin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1620479 | Free thiamin | Designated preferred name (PT) | NO | |
| RxCUI: 1620479 | Free thiamin | Full form of descriptor (FN) | NO | |
| RxCUI: 1621 | Bleomycin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1621 | Bleomycin sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 1621 | Bleomycin sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 1621 | Bleomycin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1622 | Bleomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1622 | Bleomycin | Designated preferred name (PT) | YES | |
| RxCUI: 1622 | Bleomycin | Full form of descriptor (FN) | YES | |
| RxCUI: 1622 | Bleomycin | Designated preferred name (PT) | YES | |
| RxCUI: 1622 | Bleomycin | Full form of descriptor (FN) | YES | |
| RxCUI: 1622525 | 21-deoxycorticosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1622525 | 21-deoxycorticosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1623486 | Free phenytoin | Designated preferred name (PT) | NO | |
| RxCUI: 1623486 | Free phenytoin | Full form of descriptor (FN) | NO | |
| RxCUI: 1623986 | LDL cholesterol pattern BII | Designated preferred name (PT) | NO | |
| RxCUI: 1623986 | LDL cholesterol pattern BII | Full form of descriptor (FN) | NO | |
| RxCUI: 1623986 | LDL cholesterol pattern BII | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 162592 | diethylamine salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 162592 | diethylamine salicylate | Designated preferred name (PT) | NO | |
| RxCUI: 162592 | diethylamine salicylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1626508 | Free prostate specific antigen | Designated preferred name (PT) | NO | |
| RxCUI: 1626508 | Free prostate specific antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1626536 | Free inositol | Designated preferred name (PT) | NO | |
| RxCUI: 1626536 | Free inositol | Full form of descriptor (FN) | NO | |
| RxCUI: 1626746 | Anti-Chlamydia trachomatis B IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1626746 | Anti-Chlamydia trachomatis B IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1626746 | Anti-Chlamydia trachomatis B IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1626746 | Anti-Chlamydia trachomatis B IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1627 | Blocadren | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1627003 | Creatine kinase, aberrant band | Designated preferred name (PT) | NO | |
| RxCUI: 1627003 | Creatine kinase, aberrant band | Full form of descriptor (FN) | NO | |
| RxCUI: 16272 | 7-dehydrocholesterol reductase | Designated preferred name (PT) | NO | |
| RxCUI: 16272 | 7-dehydrocholesterol reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 162723 | Dextran alpha-(1,2)-debranching enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 162723 | Dextran alpha-(1,2)-debranching enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 162723 | Dextran alpha-(1,2)-debranching enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1628461 | Galactomannan Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1628461 | Galactomannan Ag | Designated preferred name (PT) | NO | |
| RxCUI: 1628461 | Galactomannan Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 1628772 | Lipoprotein midband B | Designated preferred name (PT) | NO | |
| RxCUI: 1628772 | Lipoprotein midband B | Full form of descriptor (FN) | NO | |
| RxCUI: 1629 | Blood | Designated preferred name (PT) | NO | |
| RxCUI: 1629 | Blood | Full form of descriptor (FN) | NO | |
| RxCUI: 162901 | silver mono(2-aminoethyl)phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1629574 | Free aldosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1629574 | Free aldosterone | Full form of descriptor (FN) | NO |